Apple Watches are back on sale while federal court reviews patent suit

Apple Watches are back on the market. In a last minute win for the company, the U.S. Court of Appeals approved Apple’s request to continue selling the devices while the court reviews the International Trade Commission’s import ban.

The ITC declared that the blood oxygen measurement feature on Apple Watches was too similar to pulse oximeter company Masimo’s in October, issuing an import ban. The ban went into effect on Tuesday after President Biden declined to veto it.

Apple had paused sales of its watches with the feature earlier in the month, but remained determined to fight the ban. On Tuesday, Apple submitted an emergency motion saying it would suffer “irreparable harm” if it couldn’t sell the Watches. The court then approved Apple’s request, the company told STAT on Wednesday.

Get unlimited access to award-winning journalism and exclusive events.

Study reveals endurance exercise’s impact on the biological molecules of animals and humans

As part of an ongoing national research effort to better understand how physical activity improves health and prevents disease, seven University of Colorado Department of

May 22, 2024

RAPT Therapeutics bolsters partner search with PhII data on small molecule-Keytruda combo

RAPT Therapeutics is offering the first look at Phase II data suggesting that adding its small molecule CCR4 antagonist to Keytruda is leading to hoped-for

November 7, 2023

FDA rejects Alnylam’s heart disease treatment over insufficient data

The Food and Drug Administration rejected an Alnylam Pharmaceuticals’ therapy for an increasingly prevalent heart disease, the company said Monday, citing insufficient evidence that the

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.